Franklin Covey Company Earnings Calls
| Release date | Jul 01, 2026 |
| EPS estimate | $0.240 |
| EPS actual | $0.340 |
| EPS Surprise | 41.67% |
| Revenue estimate | 68.325M |
| Revenue actual | 67.807M |
| Revenue Surprise | -0.758% |
| Release date | Apr 01, 2026 |
| EPS estimate | $0.0250 |
| EPS actual | -$0.0300 |
| EPS Surprise | -220.00% |
| Revenue estimate | 58.7M |
| Revenue actual | 59.647M |
| Revenue Surprise | 1.61% |
| Release date | Jan 07, 2026 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0700 |
| EPS Surprise | 133.33% |
| Revenue estimate | 64.769M |
| Revenue actual | 64.045M |
| Revenue Surprise | -1.12% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.430 |
| EPS actual | $0.340 |
| EPS Surprise | -20.93% |
| Revenue estimate | 71.1M |
| Revenue actual | 71.248M |
| Revenue Surprise | 0.208% |
Last 4 Quarters for Franklin Covey Company
Below you can see how FC performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 05, 2025 |
| Price on release | $17.68 |
| EPS estimate | $0.430 |
| EPS actual | $0.340 |
| EPS surprise | -20.93% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $16.95 |
| Oct 31, 2025 | $16.98 |
| Nov 03, 2025 | $16.39 |
| Nov 04, 2025 | $16.82 |
| Nov 05, 2025 | $17.68 |
| Nov 06, 2025 | $15.90 |
| Nov 07, 2025 | $14.89 |
| Nov 10, 2025 | $14.92 |
| Nov 11, 2025 | $15.38 |
| 4 days before | 4.31% |
| 4 days after | -13.01% |
| On release day | -10.07% |
| Change in period | -9.26% |
| Release date | Jan 07, 2026 |
| Price on release | $17.82 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0700 |
| EPS surprise | 133.33% |
| Date | Price |
|---|---|
| Dec 31, 2025 | $16.78 |
| Jan 02, 2026 | $16.64 |
| Jan 05, 2026 | $17.20 |
| Jan 06, 2026 | $17.98 |
| Jan 07, 2026 | $17.82 |
| Jan 08, 2026 | $17.91 |
| Jan 09, 2026 | $18.96 |
| Jan 12, 2026 | $19.20 |
| Jan 13, 2026 | $19.40 |
| 4 days before | 6.20% |
| 4 days after | 8.87% |
| On release day | 0.505% |
| Change in period | 15.61% |
| Release date | Apr 01, 2026 |
| Price on release | $16.15 |
| EPS estimate | $0.0250 |
| EPS actual | -$0.0300 |
| EPS surprise | -220.00% |
| Date | Price |
|---|---|
| Mar 26, 2026 | $15.45 |
| Mar 27, 2026 | $15.29 |
| Mar 30, 2026 | $15.52 |
| Mar 31, 2026 | $15.79 |
| Apr 01, 2026 | $16.15 |
| Apr 02, 2026 | $23.55 |
| Apr 06, 2026 | $23.26 |
| Apr 07, 2026 | $21.98 |
| Apr 08, 2026 | $21.77 |
| 4 days before | 4.53% |
| 4 days after | 34.80% |
| On release day | 45.82% |
| Change in period | 40.91% |
| Release date | Jul 01, 2026 |
| Price on release | $24.99 |
| EPS estimate | $0.240 |
| EPS actual | $0.340 |
| EPS surprise | 41.67% |
| Date | Price |
|---|---|
| Jun 25, 2026 | $23.72 |
| Jun 26, 2026 | $24.84 |
| Jun 29, 2026 | $25.55 |
| Jun 30, 2026 | $24.53 |
| Jul 01, 2026 | $24.99 |
| Jul 02, 2026 | $21.78 |
| Jul 06, 2026 | $22.90 |
| Jul 07, 2026 | $21.69 |
| Jul 08, 2026 | $19.54 |
| 4 days before | 5.35% |
| 4 days after | -21.81% |
| On release day | -12.85% |
| Change in period | -17.62% |
Franklin Covey Company Earnings Call Transcript Summary of Q2 2026
Franklin Covey reported mixed GAAP revenue but continued operational momentum that investors should note. Reported Q2 revenue was $59.6M (flat YoY) while consolidated invoiced amounts grew 5% YoY, driven by Enterprise North America (+7%, or +10% excluding government) and Enterprise International (+7%). Deferred subscription revenue increased 16% YoY to $59M and the percentage of revenue under multiyear contracts rose to 62%, signaling a growing backlog that should convert to stronger reported revenue in fiscal 2027. Adjusted EBITDA for the quarter was $4.1M, up 99% YoY, and free cash flow was $13.2M (a sizable improvement driven mainly by AR collections). Education revenue grew 16% and is expected to be back-half weighted; International direct offices showed healthy growth (notably France and China). The company reaffirmed fiscal 2026 guidance: revenue $265–$275M and adjusted EBITDA $28–$33M, and expects the back half to be stronger (Q4 > Q3 for revenue and ~60–65% of FY adjusted EBITDA in Q4). Balance sheet and capital allocation highlights: cash on hand $13.7M, total liquidity >$76M (including a fully available $62.5M credit facility), and aggressive share repurchases (~1.6M shares for $28.1M YTD) with $20M remaining on a $50M authorization. Management frames Franklin Covey as well-positioned in an AI-driven environment because AI increases the premium on leadership, trust and disciplined execution — areas the company sells to and measures outcomes against. Continued risks include macro uncertainty, federal spending headwinds (government contracts), foreign exchange, and the timing gap between invoicing and revenue recognition.
Sign In
Buy FC